Thomas, Alissa A <br/><br/>
Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Mar 2017 
 - 379-389 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-016-1941-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bevacizumab--administration & dosage<br/>Brain Neoplasms--blood<br/>Chemoradiotherapy<br/>Cytokines--blood<br/>Dacarbazine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Glioblastoma--blood<br/>Humans<br/>Immunotherapy--methods<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Middle Aged<br/>T-Lymphocytes, Regulatory--drug effects<br/>Temozolomide<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors